By Richard Reich | Independent Life Insurance Broker | CA License #0832938 | 30+ years specializing in impaired risk and high-risk Llife Insurance placements, along with Disability Insurance and Annuities.
If you have hepatitis C, or had it in the past, you may assume life insurance is out of reach. That used to be close to true. Today it isn’t. Modern antiviral pills cure most people in eight to twelve weeks, and many life insurance companies now offer standard, and sometimes even preferred, rates to applicants who have been successfully treated. Thankfully now, it is very possible to get life insurance with Hepatitis C.
The key is knowing where you stand in the eyes of an underwriter and applying with the right company. This guide explains how hepatitis C affects life insurance, what underwriters look for, and how to get the best rate possible.
Hepatitis C – Overview
Hepatitis C is a liver infection caused by the hepatitis C virus (HCV), which spreads through contact with infected blood. Common routes include sharing needles or other drug equipment, blood transfusions and medical procedures performed before modern screening, unsterile tattoo or piercing equipment, and, less often, sexual contact or birth to a mother with the virus.
Some people clear the virus on their own after a short-term (acute) infection. Most, however, go on to develop chronic hepatitis C. Left untreated over many years, chronic infection can lead to cirrhosis, liver cancer, and liver failure.
The tricky part is that hepatitis C is often silent. Many people have no symptoms for years, sometimes decades. When symptoms do appear, they may include:
- Unusual fatigue
- Joint pain
- Pain in the abdomen or liver area
- Itchy skin
- Sore muscles
- Dark urine
- Jaundice (yellowing of the eyes and skin)
The good news is that hepatitis C is now curable. Today’s direct-acting antiviral (DAA) medications are taken as pills, usually once a day, for 8 to 12 weeks, and they cure the large majority of patients. In June 2025, the FDA expanded approval of Mavyret so it can be used to treat even recent (acute) infections, with an eight-week course and a 96% cure rate in the clinical study.
With few or no Symptoms, How do I know if I’m Infected?
Many people still find out by accident, through a blood test for life insurance, a blood donation, or routine bloodwork. That’s changing, because the CDC now recommends that every adult 18 and older be tested for hepatitis C at least once, and that pregnant women be tested during each pregnancy. People with ongoing risk factors should be tested periodically.
Testing usually happens in two steps:
- Antibody test – shows whether you’ve ever been exposed to the virus.
- HCV RNA test – shows whether the virus is still active in your blood.
A positive antibody test alone doesn’t mean you have hepatitis C today. It may mean you cleared the virus or were cured in the past. Only the RNA test confirms an active infection. In 2024, the FDA authorized the first point-of-care RNA test, which uses a fingertip blood sample and returns results in about an hour, so some patients can now be diagnosed and start treatment in a single visit.
If you are infected, your doctor will check the health of your liver. Today this is usually done with blood tests and a noninvasive scan such as FibroScan (elastography) or ultrasound, rather than a liver biopsy. These results matter a great deal for life insurance, as you’ll see below.
Treatment has also become much more affordable than it was when the first cures hit the market. Early brand-name drugs carried list prices near $95,000. Since 2019, lower-priced authorized generic versions have been available, and most health insurance plans, Medicare, and Medicaid now cover treatment. There is no reason to delay treatment, and from a life insurance standpoint, getting cured is the single best thing you can do for your rates.
Why do Baby Boomers have Hep C?
For years, people born between 1945 and 1965 made up the majority of Americans living with hepatitis C. Many were infected decades ago and never knew it.
Sharing a cocaine straw or rolled-up dollar bill may sound familiar to some of us who were young adults in the sixties and seventies, when a lot of risky behavior wasn’t considered dangerous “back in the day.” But drug use is only part of the story. Research published in The Lancet Infectious Diseases in 2016 pointed to unsafe medical procedures and blood transfusions, before the blood supply was screened for the virus, as a major driver of infection in this generation.
Hepatitis C is no longer mainly a baby boomer disease, though. The opioid epidemic has driven a wave of new infections among younger adults. According to CDC surveillance data, the rate of newly reported chronic hepatitis C cases in 2023 was highest among people aged 30 to 39. That’s a big reason the CDC moved from testing only baby boomers to recommending testing for all adults.
How Will Hepatitis C Impact Life Insurance Rates?
How hepatitis C affects your rates depends on what the underwriter learns about your current status and the health of your liver. Underwriters focus on a few key questions:
- Is the virus cured or still active? Cure is defined as a sustained virologic response (SVR), meaning the virus is undetectable at least 12 weeks after finishing treatment.
- How long ago were you cured? Many carriers offer their best rates once you’re one to two years past treatment with clean follow-up results.
- Is there liver damage? The degree of fibrosis (scarring) is often the deciding factor. Minimal or no fibrosis is viewed very differently from cirrhosis.
- What do your liver function tests show? Normal ALT and AST levels after treatment are a strong positive.
- Alcohol and drug use. Current alcohol use, a history of substance abuse, or co-infection with hepatitis B or HIV can raise rates or lead to a decline.
Here is a general picture of how applicants are often viewed. Every company has its own guidelines, so treat this as a rough guide rather than a promise:
|
Your Situation |
Typical Outcome |
|
Acute infection that cleared on its own, normal liver tests |
Often standard rates, sometimes better |
|
Cured (SVR), minimal or no fibrosis, normal liver tests, 1–2+ years post-treatment |
Standard rates possible; preferred at some carriers |
|
Cured recently, or cured with moderate fibrosis |
Standard to table-rated |
|
Active chronic infection, untreated |
Table-rated or postponed; many carriers want to see treatment first |
|
Cirrhosis, liver cancer, or ongoing alcohol/drug use |
Frequently declined for traditional coverage; guaranteed issue options remain |
If you are currently untreated, an underwriter may simply postpone your application until you’ve completed treatment. In many cases, it pays to finish treatment, confirm your cure, and then apply. An experienced broker can tell you whether it makes more sense to apply now or wait.
If you had chronic hepatitis C, expect to be treated as an applicant with a preexisting condition, which makes choosing the right carrier especially important.
What Is the Underwriting Process?
First, understand that you should apply with an insurer that is comfortable with high-risk cases. If you apply with a typical online insurer offering quick policies with little underwriting, you may be declined or offered a poor rate simply because their system can’t evaluate your history properly.
When you apply, you’ll complete an application with questions about your health and your family’s health. Once the underwriter sees a hepatitis C history, you’ll likely be asked to fill out a supplemental questionnaire about your diagnosis, treatment, and follow-up. The underwriter will typically also order:
- Life insurance medical exam – Height, weight, blood pressure, pulse, and blood and urine samples. The blood panel includes liver function tests and may include hepatitis C testing.
- Attending Physician Statements (APS) – Records from the doctors who diagnosed and treated you, usually covering the past several years. These include your RNA test results, liver scans, treatment dates, and SVR confirmation.
- MIB (Medical Information Bureau) report and prescription history check – Shows whether you’ve applied for coverage before and which medications you’ve filled.
- MVR (Motor Vehicle Report) – Your driving record, usually for the last three to five years.
Tip: Gather your records before you apply. A copy of your post-treatment RNA test showing the virus is undetectable, plus your most recent liver function tests and any FibroScan or ultrasound results, can speed up underwriting and help your broker shop your case with the right carriers.
Once all of this information has been reviewed by the underwriter, a rating class is assigned and sent to your agent. Your agent can then deliver a formal offer for you to accept or decline.
What If I’m Declined Because of Hepatitis C?
There is good news even if your application is declined. First, a decline from one company doesn’t mean a decline from all of them. Underwriting guidelines for hepatitis C vary widely, and an independent broker can take your case to carriers with more favorable rules. If you were declined while your infection was active, getting treated and reapplying after your cure is confirmed can change the outcome completely.
If traditional coverage isn’t available, an independent agent can offer alternatives such as simplified issue or guaranteed issue life insurance, which require few or no medical questions. These policies cost more and carry smaller benefit amounts, but they can provide valuable final expense coverage so your loved ones aren’t left with the bill.
Get In Touch
To get more information about purchasing High Risk Life Insurance with severe medical conditions, contact an insurance professional at LifeInsure.Com today at (866) 868-0099 during normal business hours, or you can contact us through our website 24/7.
Frequently Asked Questions
Can I get life insurance if I’ve been cured of hepatitis C?
Will I be declined if I have active hepatitis C?
Do I have to disclose hepatitis C if I’ve been cured?
Does a positive antibody test mean I have hepatitis C?
Should I apply now or wait until after treatment?
Editorial review by Sonny O’Steen, Digital Marketing Specialist with 25 years of insurance industry experience. Reviewed for clarity, organization, source references, and consistency with the cited information.
It means you need the right broker.
Reliable Sources:
- CDC – Clinical Screening and Diagnosis for Hepatitis C: CDC recommends universal hepatitis C screening for all adults 18 and older and all pregnant women during each pregnancy cdc
- CDC MMWR 2020 Screening Recommendations: direct-acting antiviral treatment can cure most people with 8–12 weeks of all-oral medication opqic
- AbbVie Mavyret acute HCV approval (via Business Wire): FDA approval in June 2025 made Mavyret the only DAA approved to treat acute HCV in eight weeks, with a 96% cure rate eatg
- FDA point-of-care RNA test (via NATAP) and EATG summary: the test detects HCV RNA from a fingertip blood sample and returns results in about an hour eatg
- CDC 2023 Surveillance, Table 3.6: in 2023, newly reported chronic hepatitis C rates were highest among people aged 30–39 cdc
- HepMag on Gilead authorized generics: the generics launched in January 2019 at a $24,000 list price, while Harvoni was originally priced at $94,500 for 12 weeks hepmag
Check out Our Other Articles About High-Risk Life Insurance
Last Updated on October 22, 2026 by Richard Reich